Skip to main content
Search
Menu
IVIS

Watch the seminar: What impact can whole body imaging have on your preclinical research?

16 December 2022, 10:46

A whole-body monitoring system with bioluminescence camera for in vivo, ex vivo and in vitro applications, which is expected to support drug development in preclinical environments, has been installed in one of the RISE laboratories in Södertälje. 

Watch the seminar on usefulness of a whole body monitoring system with bioluminescence, also called IVIS, to follow disease progression or effeciency of treatment in preclinical research.

During the past year, RISE has used the camera in collaboration with the Swedish biotech company Anocca. Anocca's business idea is to establish a unique technology platform for analysis of T-cell biology to unlock the therapeutic potential of T-cell immunity. 

Speakers: Evelina Lindmark, researcher and study director for in vivo studies at RISE, Hugh Salter, CSO Anocca, and Hannes Uchtenhagen, Translational Sciences Lead at Anocca, and Matilda Bäckberg, project manager for the Pharma Office and director for RISE laboratory animal operations. The seminar was moderated by Cecilia Hyrén, research- and business developer at RISE.